Biological E to make HPV9 vaccine in partnership with China’s Recbio

South First Desk Jun 30, 2025 Health

[{"selector":"#anim-36a6ad0f-4fee-46bf-a014-9effc81a286e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Health Biological E Limited announced a partnership with China’s Jiangsu Recbio Technology to manufacture and distribute a 9-valent Human Papillomavirus (HPV9) vaccine. Read the article

[{"selector":"#anim-fa473745-02d7-4f72-b77e-62bdab925d30 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.249999886225726%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Health The HPV9 vaccine is designed to protect against HPV types linked to cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as genital warts. Read the article

[{"selector":"#anim-e30b1b3e-d58d-42f6-8c3f-bfc61b1e5b75 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(31.231249886111957%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Health It is currently in Phase III clinical trials in China and is intended for individuals aged 9 to 45. Read the article

[{"selector":"#anim-a85b47c7-683f-409b-919c-b3d6f59cd642 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-27.499999863470876%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Health BE said the agreement marks the start of a technology transfer process that will enable the company to manufacture and commercialise the vaccine in India and in global markets. Read the article

[{"selector":"#anim-c620b628-b1c8-4382-b899-0211885cddff [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(22.139397207670548%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Health The global burden of HPV-related cancers remains substantial, with the virus accounting for an estimated 620,000 cancer cases in women and 70,000 in men in 2019. Read the article